<DOC>
	<DOCNO>NCT00184587</DOCNO>
	<brief_summary>The purpose study determine whether candesartan cilexetil effective prophylactic treatment episodic Cluster headache</brief_summary>
	<brief_title>Prophylactic Treatment Episodic Cluster Headache</brief_title>
	<detailed_description>Cluster headache unilateral headache periodic attack , usually last 6 12 week . The pain usually unbearable . The attack treat injection sumatriptan ( migraine medication ) inhalation oxygen . The common prophylactic today limit effect risk side effect . Candesartan one study show clinically significant effect migraine prophylaxis . The angiotensin II receptor blocker , candesartan well tolerate side-effects significantly different placebo drug interaction . We therefore wish investigate prophylactic effect treatment cluster headache patient . This multicenter , double-blind , randomize , parallel study prophylactic effect candesartan compare placebo period 3 week . First week 16 mg follow 2 week 32 mg .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>The episodic cluster headache must diagnose accord IHS classification . Had least one episode cluster headache inclusion . Previously least one cluster headache episode last one month . At time inclusion , cluster headache period shall last 3 week Pregnancy , nursing , decrease hepatic og renal function , psychiatric illness , cardiac problem , hypersensitivity candesartan , previous serious allergic reaction medication , chronic cluster headache , drug/alcohol abuse , use antipsychotic , antidepressant , lithium prophylactic treatment le one month prior inclusion , systolic blood pressure 110 mmHg , use hypertensive medication , use og specific attack medication sumatriptan injection oxygen 710l/min inability change medication , use triptans sumatriptan study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>prophylactic</keyword>
	<keyword>episodic</keyword>
	<keyword>cluster</keyword>
	<keyword>candesartan</keyword>
	<keyword>angiotensin II receptor blocker</keyword>
	<keyword>randomize placebo control parallel study</keyword>
	<keyword>headache diary</keyword>
</DOC>